General Information About the Bloomington Deficiency Kit
Updated July 22, 2009
Stock Center logo

The Bloomington Deficiency Kit provides maximal coverage of the genome with the minimal number of deletions having molecularly mapped breakpoints. Regions not covered by molecularly defined deletions exist as gaps in coverage or they are deleted by cytologically defined deficiencies. Haplolethal and haplosterile loci (described in Marygold et al., 2007) are flanked as closely as possible with deletions as well as being covered by deletions when possible.

The molecularly defined deletions were generated primarily by the Bloomington Deletion Project, the DrosDel Project and Exelixis, Inc. from FRT-bearing transposable element insertions. Breakpoints have usually been mapped to single-base resolution. Other deletions have typically been characterized by polytene cytology and complementation tests with molecularly mapped mutations.

Arm # of euchromatic genes # undeleted euchromatic genes % euchromatic coverage Number of stocks Download spreadsheet
1 2288 102 95.5 84 DK1
2L 2765 45 98.4 101 DK2L
2R 3089 57 98.2 94 DK2R
3L 2845 68 97.6 80 DK3L
3R 3535 47 98.7 103 DK3R
4 88 5 94.3 7 DK4
All 14610 324 97.8 468  
Recent Changes to the Kit
July 2009
  • New DK established. No changes yet.